Neuroprotective Effects of Qingnao Dripping Pills Against Cerebral Ischemia via Inhibiting NLRP3 Inflammasome Signaling Pathway: In Vivo and In Vitro

• Published in: Frontiers in pharmacology 2020-02, Vol.11, p.65-65
• Main Authors: Fu, Chen, Zhang, Xinyang, Zeng, Zixiu, Tian, Yang, Jin, Xianglan, Wang, Fengli, Xu, Zhenmin, Chen, Baoxin, Zheng, Hong, Liu, Xuemei
• Format: Article
• Language: English
• Subjects: apoptosis; cerebral ischemia; inflammatory response; middle cerebral artery occlusion; NOD-like receptor family pyrin domain containing 3 inflammasome; Pharmacology; Qingnao dripping pills
• ISSN: 1663-9812; 1663-9812
• DOI: 10.3389/fphar.2020.00065

Ischemic stroke patients suffer from relatively limited treatment options. Studies have shown that in cerebral ischemia, NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome is a key mediator in mediating inflammatory responses and results in activation of apoptosis signaling pathways. Here we assessed the and effects of Qingnao Dripping Pills (QNDP), a traditional Chinese prescription, on inflammatory responses and apoptosis. Our results showed that QNDP could significantly decrease cerebral ischemia injury, improve neurological function and inhibit apoptosis in rats impaired by middle cerebral artery occlusion (MCAO). Further, we found that QNDP inhibited NLRP3 inflammasome expression both in MCAO rats and in SH-SY5Y cells under OGD. Moreover, the levels of inflammatory cytokines including interleukin-1β (IL-1β) and IL-18, which mediated by NLRP3 inflammasome and increased in MCAO rats, could be reduced by QNDP, suggesting that QNDP could protect the neurons against inflammation through a mechanism mediated by NLRP3 inflammasome. Nuclear factor-kappa B (NF-κB) was also involved in the anti-inflammatory effect of QNDP. In conclusion, QNDP had neuroprotective effects against cerebral ischemia inhibiting NLRP3 inflammasome signaling pathway, and was a potential candidate for the future treatment of ischemic stroke.